Search Within

Mark Weiss

  1. "Molecular Pharmacology and Chemistry Program Faculty"
Formats
  1. Meeting Abstract (26)
  2. Journal Article (11)
  3. Book Section (4)
Groups
  1. Adult Leukemia (41)
  2. Center for Hematologic Malignancies (41)
  3. Department of Medicine (41)
  4. GSK Faculty (41)
  5. Hematologic Malignancies Research (41)
  6. Hematologic Malignancies, Division of (41)

More Groups

People
  1. David Scheinberg (38)
  2. Peter Maslak (34)
  3. Joseph Jurcic (18)
  4. Nicole Lamanna (11)
  5. Ellin Berman (10)
  6. Denise Horgan (9)

More People

Years
  1. 2014 (1)
  2. 2010 (1)
  3. 2009 (2)
  4. 2008 (2)
  5. 2006 (1)
  6. 2005 (4)

More Years

Publications
  1. Blood (23)
  2. Journal of Clinical Oncology (7)
  3. Leukemia (4)
  4. Cancer: Principles and Practice of Oncology. 5th ed (2)
  5. Cancer (1)
  6. Cancer: Principles and Practice of Oncology. 6th ed (1)

More Publications

Publishers
  1. American Society of Hematology (23)
  2. American Society of Clinical Oncology (7)
  3. Nature Publishing Group (5)
  4. Lippincott Williams & Wilkins (2)
  5. Lippincott-Raven (2)
  6. Elsevier Inc. (1)

More Publishers

Results (41)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Induction with combined modality therapy followed by immunomodulated post remission therapy for newly diagnosed acute myeloid leukemia (AML)
    Meeting Abstract

    Gupta, S.; Weiss, M. A.; Jurcic, J. G.; Chanel, S.; Wilson, B. A.; Biederman, E.; Berman, E.; Scheinberg, D. A.; Maslak, P. G.
    Blood (2005)

    Fulltext@MSK | Save
  • Pentostatin and cyclophosphamide compared to pentostatin, cyclophosphamide, and rituximab as salvage therapy for patients with chronic lymphocytic leukemia
    Meeting Abstract

    Weiss, M. A.; Lamanna, N.; Kalaycio, M.; Jurcic, J.; Maslak, P.; Gencarelli, A.; Scheinberg, D.; Horgan, D.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • Sequential therapy with cytarabine and bismuth-213 (Bi-213)-labeled-HuM195 (anti-CD33) for acute myeloid leukemia (AML)
    Meeting Abstract

    Mulford, D. A.; Pandit-Taskar, N.; McDevitt, M. R.; Finn, R. D.; Weiss, M. A.; Apostolidis, C.; Morgenstern, A.; Divgi, C. R.; Larson, S. M.; Scheinberg, D. A.; more...
    Blood (2004)

    Fulltext@MSK | Save
  • Pentostatin and cyclophosphamide with or without rituximab has significant activity in patients with previously treated chronic lymphocytic leukemia and other low grade lymphoid neoplasms
    Meeting Abstract

    Lamanna, N.; Kalaycio, M.; Maslak, P.; Jurcic, J.; Scheinberg, D. A.; Gencarelli, A. N.; Horgan, D.; Weiss, M. A.
    Blood (2004)

    Fulltext@MSK | Save
  • Pentostatin, cydophosphamide, and rituximab (PCR therapy): A new active regimen for previously treated patients with chronic lymphocytic leukemia (CLL)
    Meeting Abstract

    Weiss, M. A.; Lamanna, N.; Jurcic, J. G.; Maslak, P. G.; Vonhassel, M.; Horgan, D.; Scheinberg, D. A.; Gencarelli, A. N.
    Blood (2003)

    Fulltext@MSK | Save
  • Reducing standard postremission chemotherapy in acute promyelocytic leukemia (APL) with risk-adapted therapy
    Meeting Abstract

    Mulford, D. A.; Maslak, P. G.; Weiss, M. A.; Scheinberg, D. A.; Jurcic, J. G.
    Blood (2003)

    Fulltext@MSK | Save
  • Sequential therapy with fludarabine, high dose cyclophosphamide, and rituximab induces a high incidence of complete response in patients with chronic lymphocytic leukemia (CLL)
    Meeting Abstract

    Lamanna, N.; Weiss, M. A.; Maslak, P. G.; Gencarelli, A. N.; Scheinberg, D. A.; Horgan, D.
    Blood (2003)

    Fulltext@MSK | Save
  • Pentostatin and cyclophosphamide: An effective new regimen in previously treated patients with chronic lymphocytic leukemia
    Journal Article

    Weiss, M. A.; Maslak, P. G.; Jurcic, J. G.; Scheinberg, D. A.; Aliff, T. B.; Lamanna, N.; Frankel, S. R.; Kossman, S. E.; Horgan, D.
    Journal of Clinical Oncology (2003)

    Fulltext@MSK | Save
  • Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15
    Journal Article

    Brentjens, R. J.; Latouche, J. B.; Santos, E.; Marti, F.; Gong, M. C.; Lyddane, C.; King, P. D.; Larson, S.; Weiss, M.; RivieĢ€re, I.; more...
    Nature Medicine (2003)

    Fulltext@MSK | Save
  • Sequential therapy with fludarabine, high dose cyclophosphamide, and rituximab improves the quality of response in patients with previously untreated chronic lymphocytic leukemia
    Meeting Abstract

    Weiss, M. A.; Lamanna, N.; Gencarelli, A.; Scheinberg, D. A.; Maslak, P. G.; Horgan, D.
    Blood (2002)

    Fulltext@MSK | Save